Reviva Pharmaceuticals Holdings Inc (RVPH)
1.66
-0.05
(-2.92%)
USD |
NASDAQ |
May 17, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Cash from Financing (TTM): 32.82M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 32.82M |
December 31, 2023 | 33.17M |
September 30, 2023 | 5.919M |
June 30, 2023 | 13.69M |
March 31, 2023 | 8.480M |
December 31, 2022 | 7.792M |
Date | Value |
---|---|
September 30, 2022 | 7.872M |
June 30, 2022 | 0.0986M |
March 31, 2022 | 31.60M |
December 31, 2021 | 31.60M |
September 30, 2021 | 42.84M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.0986M
Minimum
Jun 2022
42.84M
Maximum
Sep 2021
19.63M
Average
13.69M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
AbbVie Inc | -211.00M |
ABVC BioPharma Inc | 3.919M |
Sutro Biopharma Inc | 125.37M |
Flora Growth Corp | 3.15M |
Journey Medical Corp | -3.219M |